JP2013166767A - 高齢者に対する長期栄養供給 - Google Patents
高齢者に対する長期栄養供給 Download PDFInfo
- Publication number
- JP2013166767A JP2013166767A JP2013082097A JP2013082097A JP2013166767A JP 2013166767 A JP2013166767 A JP 2013166767A JP 2013082097 A JP2013082097 A JP 2013082097A JP 2013082097 A JP2013082097 A JP 2013082097A JP 2013166767 A JP2013166767 A JP 2013166767A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- source
- kcal
- per
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000007774 longterm Effects 0.000 title claims abstract description 23
- 235000015097 nutrients Nutrition 0.000 title abstract description 5
- 239000000203 mixture Substances 0.000 claims abstract description 65
- 235000018102 proteins Nutrition 0.000 claims abstract description 27
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 27
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 27
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 22
- 235000014633 carbohydrates Nutrition 0.000 claims abstract description 22
- 239000000835 fiber Substances 0.000 claims abstract description 20
- 150000002632 lipids Chemical class 0.000 claims abstract description 19
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 13
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000011651 chromium Substances 0.000 claims abstract description 12
- 229910052804 chromium Inorganic materials 0.000 claims abstract description 12
- 150000004671 saturated fatty acids Chemical class 0.000 claims abstract description 12
- 235000021281 monounsaturated fatty acids Nutrition 0.000 claims abstract description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 5
- 239000011707 mineral Substances 0.000 claims abstract description 5
- 229940088594 vitamin Drugs 0.000 claims abstract description 5
- 229930003231 vitamin Natural products 0.000 claims abstract description 5
- 235000013343 vitamin Nutrition 0.000 claims abstract description 5
- 239000011782 vitamin Substances 0.000 claims abstract description 5
- 230000033228 biological regulation Effects 0.000 claims abstract description 3
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 16
- 229930091371 Fructose Natural products 0.000 claims description 14
- 239000005715 Fructose Substances 0.000 claims description 14
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 14
- 108010046377 Whey Proteins Proteins 0.000 claims description 13
- 102000007544 Whey Proteins Human genes 0.000 claims description 13
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 9
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 9
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 9
- 235000013734 beta-carotene Nutrition 0.000 claims description 9
- 239000011648 beta-carotene Substances 0.000 claims description 9
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 9
- 229960002747 betacarotene Drugs 0.000 claims description 9
- 239000005018 casein Substances 0.000 claims description 9
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 9
- 235000021240 caseins Nutrition 0.000 claims description 9
- 235000012680 lutein Nutrition 0.000 claims description 9
- 239000001656 lutein Substances 0.000 claims description 9
- 229960005375 lutein Drugs 0.000 claims description 9
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 9
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 9
- 235000012661 lycopene Nutrition 0.000 claims description 9
- 239000001751 lycopene Substances 0.000 claims description 9
- 229960004999 lycopene Drugs 0.000 claims description 9
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 9
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 9
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 9
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 9
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 9
- PHIQHXFUZVPYII-ZCFIWIBFSA-O (R)-carnitinium Chemical compound C[N+](C)(C)C[C@H](O)CC(O)=O PHIQHXFUZVPYII-ZCFIWIBFSA-O 0.000 claims description 8
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 8
- 229960004203 carnitine Drugs 0.000 claims description 8
- 229960001231 choline Drugs 0.000 claims description 8
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 8
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 8
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims description 8
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 8
- 229960003080 taurine Drugs 0.000 claims description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 6
- 229930003316 Vitamin D Natural products 0.000 claims description 6
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 6
- 239000011575 calcium Substances 0.000 claims description 6
- 229910052791 calcium Inorganic materials 0.000 claims description 6
- 235000019166 vitamin D Nutrition 0.000 claims description 6
- 239000011710 vitamin D Substances 0.000 claims description 6
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 6
- 229940046008 vitamin d Drugs 0.000 claims description 6
- 235000021119 whey protein Nutrition 0.000 claims description 6
- 235000019197 fats Nutrition 0.000 claims description 5
- 230000002641 glycemic effect Effects 0.000 claims description 5
- 230000004044 response Effects 0.000 claims description 5
- 108010073771 Soybean Proteins Proteins 0.000 claims description 4
- 229940001941 soy protein Drugs 0.000 claims description 4
- 235000013406 prebiotics Nutrition 0.000 claims description 3
- -1 calcium Chemical class 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 41
- 235000010755 mineral Nutrition 0.000 abstract description 4
- 102000004506 Blood Proteins Human genes 0.000 abstract 1
- 108010017384 Blood Proteins Proteins 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 description 30
- 230000035764 nutrition Effects 0.000 description 21
- 238000009472 formulation Methods 0.000 description 9
- 229920001353 Dextrin Polymers 0.000 description 7
- 239000004375 Dextrin Substances 0.000 description 7
- 229920002774 Maltodextrin Polymers 0.000 description 7
- 239000005913 Maltodextrin Substances 0.000 description 7
- 229920002472 Starch Polymers 0.000 description 7
- 239000005862 Whey Substances 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 235000019425 dextrin Nutrition 0.000 description 7
- 229940035034 maltodextrin Drugs 0.000 description 7
- 239000008107 starch Substances 0.000 description 7
- 235000019698 starch Nutrition 0.000 description 7
- 150000005846 sugar alcohols Chemical class 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 201000001421 hyperglycemia Diseases 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 235000021084 monounsaturated fats Nutrition 0.000 description 4
- 235000021590 normal diet Nutrition 0.000 description 4
- 235000003441 saturated fatty acids Nutrition 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 244000300264 Spinacia oleracea Species 0.000 description 2
- 235000009337 Spinacia oleracea Nutrition 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 235000012055 fruits and vegetables Nutrition 0.000 description 2
- 208000014829 head and neck neoplasm Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 229940057917 medium chain triglycerides Drugs 0.000 description 2
- 239000011785 micronutrient Substances 0.000 description 2
- 235000013369 micronutrients Nutrition 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010065687 Bone loss Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 208000002705 Glucose Intolerance Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- NBZANZVJRKXVBH-ITUXNECMSA-N all-trans-alpha-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CCCC2(C)C)C NBZANZVJRKXVBH-ITUXNECMSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 235000004251 balanced diet Nutrition 0.000 description 1
- 235000002360 beta-cryptoxanthin Nutrition 0.000 description 1
- 239000011774 beta-cryptoxanthin Substances 0.000 description 1
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000021074 carbohydrate intake Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 101150010415 eat-5 gene Proteins 0.000 description 1
- 210000003989 endothelium vascular Anatomy 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000014101 glucose homeostasis Effects 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 208000019016 inability to swallow Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000021073 macronutrients Nutrition 0.000 description 1
- 208000026037 malignant tumor of neck Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000020938 metabolic status Nutrition 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 235000016236 parenteral nutrition Nutrition 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 201000009104 prediabetes syndrome Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pediatric Medicine (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicinal Preparation (AREA)
Abstract
【解決手段】カロリー含量ベースで製品の14〜20%を構成するタンパク質源と、カロリー含量ベースで製品の10〜45%を構成する炭水化物源と、カロリー含量ベースで製品の30〜45%を構成する脂質源と、組成物1L当たり10〜25gを供給し、可溶性繊維及び不溶性繊維の両方を含む食物繊維源であり、前記繊維の少なくとも25重量%が可溶性である食物繊維源と、組成物100kcal当たり8.0〜18.0μgのクロムと政府規制を満たすミネラル及びビタミンを含み、タンパク質源の50重量%以上が乳清タンパク質であり、脂肪源が40〜60重量%の一価不飽和脂肪酸と、0.4〜2.0重量%のEPAであり、組成物100kcal当り1.1g以下の飽和脂肪酸とを含む組成物。
【選択図】なし
Description
1.高齢患者に、少なくとも1日1回、長期に栄養製品を経管投与するステップを含む、高齢患者に経管栄養を供給する方法であって、前記製品が、
カロリー含量ベースで前記製品の14から20%を構成するタンパク質源、
カロリー含量ベースで前記製品の10から50%を構成する炭水化物源、
カロリー含量ベースで前記製品の30から45%を構成する脂質源、
前記製品1リットル当たり10から25グラムを供給する食物繊維源、及び
前記製品100kcal当たり8.0から18.0マイクログラムのクロム
を含む、方法。
2.前記脂質が、40から60重量%の一価不飽和脂肪を含む、実施形態1に記載の方法。
3.前記繊維の少なくとも25重量%が可溶性である、実施形態1に記載の方法。
4.前記タンパク質源が、カゼイン、乳清及び大豆からなる群から選択される、実施形態1に記載の方法。
5.前記炭水化物が、果糖、糖アルコール、デンプン、デキストリン及びマルトデキストリンからなる群から選択される、実施形態1に記載の方法。
6.前記製品が、100kcal当たり1.1グラム以下の飽和脂肪酸を含む、実施形態1に記載の方法。
7.前記製品が、エイコサペンタエン酸としての0.4から2.0重量%の前記脂質を含む、実施形態1に記載の方法。
8.前記製品が、100kcal当たり少なくとも、
コリン30mg、
タウリン5.0mg、及び
カルニチン3.0mg
を含む、実施形態1に記載の方法。
9.前記製品が、100kcal当たり少なくとも、
β−カロテン0.1mg、
リコペン0.2mg、及び
ルテイン0.05mg
のうち1つ又は複数を含む、実施形態1に記載の方法。
10.エネルギー密度が0.8から1.3kcal/mlである、実施形態1に記載の方法。
11.前記食物繊維源が、可溶性繊維及び不溶性繊維の両方を供給する、実施形態1に記載の方法。
12.前記製品がプレバイオティックを含む、実施形態1に記載の方法。
13.少なくとも1日1回、長期に組成物を経管投与するステップを含む、高齢患者に栄養を供給する方法であって、前記組成物が、
タンパク質源、
脂肪源、
炭水化物源により供給される前記組成物のエネルギーの44%以下、
少なくとも25重量%の可溶性繊維を含む食物繊維源、
製品100kcal当たりクロムにより供給される少なくとも8.0マイクログラム、
ビタミンD、及び
カルシウム
を含む方法。
14.前記ビタミンDが、100kcal当たり少なくとも0.5マイクログラムを構成する、実施形態13に記載の方法。
15.前記カルシウムが、100kcal当たり少なくとも35mgを構成する、実施形態13に記載の方法。
16.前記タンパク質源が、カゼイン、乳清及び大豆からなる群から選択される、実施形態13に記載の方法。
17.前記炭水化物が、果糖、糖アルコール、デンプン、デキストリン及びマルトデキストリンからなる群から選択される、実施形態13に記載の方法。
18.前記製品が、100kcal当たり1.1グラム以下の飽和脂肪酸を含む、実施形態13に記載の方法。
19.前記製品が、100kcal当たり少なくとも、
コリン30mg、
タウリン5.0mg、及び
カルニチン3.0mg
を含む、実施形態13に記載の方法。
20.前記製品が、100kcal当たり少なくとも、
β−カロテン0.1mg、
リコペン0.2mg、及び
ルテイン0.05mg
を含む、実施形態13に記載の方法。
21.エネルギー密度が0.8から1.3kcal/mである、実施形態13に記載の方法。
22.長期経管栄養を供給するための組成物であって、
カロリー含量ベースで製品の14から20%を構成するタンパク質源と、
カロリー含量ベースで製品の10から50%を構成する炭水化物源と、
カロリー含量ベースで製品の30から45%を構成する脂質源と、
製品1リットル当たり10から25グラムを供給し、可溶性繊維及び不溶性繊維の両方を含む食物繊維源であり、前記繊維の少なくとも25重量%が可溶性である食物繊維源と、
製品100kcal当たり8.0から18.0マイクログラムのクロムと
を含み、
製品が、政府規制を満たす十分なミネラル及びビタミンを含む、組成物。
23.前記脂質が、40から60重量%の一価不飽和脂肪を含む、実施形態22に記載の製品。
24.前記タンパク質源が、カゼイン、乳清及び大豆からなる群から選択される、実施形態22に記載の製品。
25.前記炭水化物が、果糖、糖アルコール、デンプン、デキストリン及びマルトデキストリンからなる群から選択される、実施形態22に記載の製品。
26.100kcal当たり1.1グラム以下の飽和脂肪酸を含む、実施形態22に記載の製品。
27.エイコサペンタエン酸としての0.4から2.0重量%の前記脂質を含む、実施形態22に記載の製品。
28.100kcal当たり少なくとも、
コリン30mg、
タウリン5.0mg、及び
カルニチン3.0mg
を含む、実施形態22に記載の製品。
29.100kcal当たり少なくとも、
β−カロテン0.1mg、
リコペン0.2mg、及び
ルテイン0.05mg
を含む、実施形態22に記載の製品。
30.エネルギー密度が0.8から1.3kcal/mlである、実施形態22に記載の製品。
Claims (18)
- 長期経管栄養を高齢患者に供給するための組成物であって、
カロリー含量ベースで製品の14から20%を構成するタンパク質源と、
カロリー含量ベースで製品の10から45%を構成する炭水化物源と、
カロリー含量ベースで製品の30から45%を構成する脂質源と、
組成物1リットル当たり10から25グラムを供給し、可溶性繊維及び不溶性繊維の両方を含む食物繊維源であり、前記繊維の少なくとも25重量%が可溶性である食物繊維源と、
組成物100kcal当たり8.0から18.0マイクログラムのクロムと
を含み、
組成物が、政府規制を満たす十分なミネラル及びビタミンを含み、
前記タンパク質源の少なくとも50重量%が乳清タンパク質であり、
前記炭水化物源が、血糖応答が低くなるように、果糖を含むように選択され、
前記脂質源が、40〜60重量%の一価不飽和脂肪酸を含み、0.4から2.0重量%のエイコサペンタエン酸を含み、組成物100kcal当たり1.1グラム以下の飽和脂肪酸を含む、
組成物。 - 前記タンパク質源が、乳清タンパク質60重量%及び大豆タンパク質40重量%の混合物である、請求項1に記載の組成物。
- 前記タンパク質源が、さらに、カゼイン又は大豆を含む、請求項1に記載の組成物。
- 100kcal当たり少なくとも、
コリン30mg、
タウリン5.0mg、及び
カルニチン3.0mg
を含む、請求項1に記載の組成物。 - 100kcal当たり少なくとも、
β−カロテン0.1mg、
リコペン0.2mg、及び
ルテイン0.05mg
を含む、請求項1に記載の組成物。 - エネルギー密度が0.8から1.3kcal/mlである、請求項1に記載の組成物。
- 前記組成物が、高齢患者に、少なくとも1日1回、長期に経管投与される、請求項1〜6いずれか一項に記載の組成物。
- 前記繊維の少なくとも25重量%が可溶性である、請求項1〜6いずれか一項に記載の組成物。
- 前記食物繊維源が、可溶性繊維及び不溶性繊維の両方を供給する、請求項1〜6いずれか一項に記載の組成物。
- 前記組成物がプレバイオティックを含む、請求項1〜6いずれか一項に記載の組成物。
- 長期に、少なくとも1日に1回経管栄養を高齢患者に供給するための組成物であって、
タンパク質源と、
脂肪源と、
前記組成物のエネルギーの44%以下を供給する炭水化物源と、
少なくとも25重量%の可溶性繊維を含む食物繊維源と、
組成物100kcal当たり少なくとも8.0マイクログラムのクロムと、
ビタミンDと、
カルシウムと
を含み、
前記タンパク質源の少なくとも50重量%が乳清タンパク質であり、
前記炭水化物源が、血糖応答が低くなるように、果糖を含むように選択され、
前記脂肪源が、40〜60重量%の一価不飽和脂肪酸を含み、0.4から2.0重量%のエイコサペンタエン酸を含み、組成物100kcal当たり1.1グラム以下の飽和脂肪酸を含む、
組成物。 - 前記タンパク質源が、乳清タンパク質60重量%及び大豆タンパク質40重量%の混合物である、請求項11に記載の組成物。
- 前記ビタミンDが、100kcal当たり少なくとも0.5マイクログラムを構成する、請求項11に記載の組成物。
- 前記カルシウムが、100kcal当たり少なくとも35mgを構成する、請求項11に記載の組成物。
- 前記タンパク質源が、さらに、カゼイン又は大豆を含む、請求項11に記載の組成物。
- 100kcal当たり少なくとも、
コリン30mg、
タウリン5.0mg、及び
カルニチン3.0mg
を含む、請求項11に記載の組成物。 - 100kcal当たり少なくとも、
β−カロテン0.1mg、
リコペン0.2mg、及び
ルテイン0.05mg
を含む、請求項11に記載の組成物。 - エネルギー密度が0.8から1.3kcal/mlである、請求項11に記載の組成物。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86215606P | 2006-10-19 | 2006-10-19 | |
US60/862,156 | 2006-10-19 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009532799A Division JP2010513226A (ja) | 2006-10-19 | 2007-10-17 | 高齢者に対する長期栄養供給 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2013166767A true JP2013166767A (ja) | 2013-08-29 |
JP6096571B2 JP6096571B2 (ja) | 2017-03-15 |
Family
ID=39185934
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009532799A Pending JP2010513226A (ja) | 2006-10-19 | 2007-10-17 | 高齢者に対する長期栄養供給 |
JP2013082097A Expired - Fee Related JP6096571B2 (ja) | 2006-10-19 | 2013-04-10 | 高齢者に対する長期栄養供給 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009532799A Pending JP2010513226A (ja) | 2006-10-19 | 2007-10-17 | 高齢者に対する長期栄養供給 |
Country Status (15)
Country | Link |
---|---|
US (2) | US20100094246A1 (ja) |
EP (1) | EP2081449A2 (ja) |
JP (2) | JP2010513226A (ja) |
CN (2) | CN101522056A (ja) |
AU (1) | AU2007312284B2 (ja) |
BR (1) | BRPI0717410A2 (ja) |
CA (1) | CA2664139C (ja) |
CL (1) | CL2007003018A1 (ja) |
CO (1) | CO6160277A2 (ja) |
IL (1) | IL197475A0 (ja) |
MX (1) | MX2009003239A (ja) |
MY (1) | MY148276A (ja) |
RU (1) | RU2406411C1 (ja) |
WO (1) | WO2008046865A2 (ja) |
ZA (1) | ZA200903406B (ja) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI492744B (zh) | 2009-12-04 | 2015-07-21 | Abbott Lab | 使用類胡蘿蔔素調節早產兒發炎症之方法 |
WO2011071365A1 (en) * | 2009-12-07 | 2011-06-16 | N.V. Nutricia | Balanced fat composition and use thereof in a liquid nutritional composition suitable for enteral feeding |
BR112012033422B8 (pt) * | 2010-06-28 | 2021-05-11 | Nestec Sa | formulação de alimentação por sonda de alimentação diária completa, seu uso e seu método de fabricação |
US8183227B1 (en) | 2011-07-07 | 2012-05-22 | Chemo S. A. France | Compositions, kits and methods for nutrition supplementation |
US8168611B1 (en) | 2011-09-29 | 2012-05-01 | Chemo S.A. France | Compositions, kits and methods for nutrition supplementation |
CN102366105B (zh) * | 2011-10-29 | 2012-12-05 | 山西振东五和健康食品股份有限公司 | 一种适用于中老年女性机能维持的食品 |
AU2013204445B2 (en) * | 2012-03-13 | 2014-10-02 | Sapporo Holdings Limited | Nutritionally balanced food or beverage product |
WO2017132257A1 (en) * | 2016-01-25 | 2017-08-03 | Adm Edible Beans Specialty, Inc. | Improved pulse processing and products produced therefrom |
CN110584093A (zh) * | 2019-08-08 | 2019-12-20 | 田伟盟 | 一种老年鼻饲患者匀浆膳 |
CN111838321A (zh) * | 2020-08-18 | 2020-10-30 | 青岛大学 | 一种含叶黄素和益生元的老年营养包及其制备方法 |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06253774A (ja) * | 1993-03-08 | 1994-09-13 | Shinichi Sakai | 健康食品として優れたマヨネ−ズソ−スの製造法 |
JPH08231411A (ja) * | 1995-01-13 | 1996-09-10 | Clintec Nutrition Co | 年配患者への栄養供給方法 |
JP2001316274A (ja) * | 2000-05-08 | 2001-11-13 | Asahi Kasei Corp | 経管栄養剤およびその製造方法 |
WO2003022288A1 (fr) * | 2001-09-07 | 2003-03-20 | Meiji Dairies Corporation | Compositions nutritionnelles permettant de reguler le niveau de glucose sanguin |
JP2004527501A (ja) * | 2001-03-05 | 2004-09-09 | ピー. アーネスト,スティーヴン | 経腸処方 |
JP2005261384A (ja) * | 2004-03-22 | 2005-09-29 | Yasuko Morita | クルミ和え衣及びクルミ豆腐 |
JP2006094740A (ja) * | 2004-09-29 | 2006-04-13 | Asama Chemical Co Ltd | 乳清タンパク食品 |
JP2006104147A (ja) * | 2004-10-07 | 2006-04-20 | Otsuka Pharmaceut Factory Inc | 経口・経腸栄養組成物 |
JP2006131611A (ja) * | 2004-10-07 | 2006-05-25 | Otsuka Pharmaceut Factory Inc | 骨代謝・たんぱく質代謝改善用栄養組成物 |
JP2006149371A (ja) * | 2004-08-24 | 2006-06-15 | Asama Chemical Co Ltd | 乳清タンパク食品 |
JP2006230346A (ja) * | 2005-02-28 | 2006-09-07 | Asama Chemical Co Ltd | 分散性の改善された乳由来のタンパク組成物 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4704111A (en) * | 1983-04-22 | 1987-11-03 | Moss James P | Nasogastric feeding tube |
US5017193A (en) * | 1988-09-26 | 1991-05-21 | Tri-State Hospital Supply Corp. | Infant feeding device |
US5104677A (en) | 1991-06-27 | 1992-04-14 | Abbott Laboratories | Liquid nutritional product |
US5403290A (en) * | 1992-04-20 | 1995-04-04 | Noble; Lisa W. | Gastric adapter/stopcock |
US5472952A (en) * | 1993-03-18 | 1995-12-05 | Bristol-Myers Squibb Company | Partially hydrolyzed pectin in nutritional compositions |
US5460603A (en) * | 1993-04-08 | 1995-10-24 | Massachusetts Institute Of Technology | Method and apparatus for preventing back flow in gastroenterological feeding system |
US5700782A (en) * | 1993-05-28 | 1997-12-23 | Abbott Laboratories | Enteral nutritional product |
CA2162042C (en) * | 1993-05-28 | 1999-02-23 | Frederick Oliver Cope | Enteral nutritional product |
US5531681A (en) * | 1995-01-13 | 1996-07-02 | Abbott Laboratories | Apparatus for altering composition of nutritional product during enteral tube feeding |
DE69506095T2 (de) * | 1995-08-04 | 1999-06-24 | Nutricia Nv | Diätfasern enthaltende Nahrungszusammensetzung |
US5985339A (en) * | 1996-11-22 | 1999-11-16 | Kamarei; A. Reza | Refrigeration-shelf-stable ready-to-drink complete nutritional compositions and products |
DE19838636A1 (de) * | 1998-08-26 | 2000-03-02 | Basf Ag | Carotinoid-Formulierungen, enthaltend ein Gemisch aus beta-Carotin, Lycopin und Lutein |
US6355609B1 (en) * | 1999-04-14 | 2002-03-12 | Nestec S.A. | Methods for stabilizing liquid nutritional products and products so stabilized |
EP1090636A1 (en) * | 1999-09-13 | 2001-04-11 | Société des Produits Nestlé S.A. | High lipid diet |
US6989161B2 (en) * | 2000-06-12 | 2006-01-24 | Access Business Group International Llc | Phytonutrient nutritional supplement |
CA2427289C (en) * | 2000-11-16 | 2006-10-31 | Morinaga Milk Industry Co., Ltd. | Fat composition and hexacosanoic acid depressant for oral or enteral administration |
DE10109798A1 (de) * | 2001-03-01 | 2002-09-12 | Aventis Pharma Gmbh | Gesundheitsfördernde Zusammensetzung von Verbindungen |
JP2004515508A (ja) * | 2000-12-16 | 2004-05-27 | アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 化合物の健康促進組成物 |
US20020198502A1 (en) * | 2001-06-21 | 2002-12-26 | Luke Vohsing | Medical occlusion prevention apparatus and method |
US20030104033A1 (en) * | 2001-07-13 | 2003-06-05 | Lai Chon-Si | Enteral formulations |
ES2282880T3 (es) * | 2003-05-22 | 2007-10-16 | N.V. Nutricia | Metodo para tratar o prevenir heridas cronicas y composicion nutritiv a completa comprendiendo glicina y/o leucina para usar en este. |
ES2677868T3 (es) * | 2003-10-16 | 2018-08-07 | Nestec S.A. | Composición nutricional frente a los efectos secundarios de la quimioterapia o de la radioterapia |
US7090879B2 (en) * | 2004-03-18 | 2006-08-15 | Abbott Laboratories | Nutritional formula containing select carotenoid combinations |
KR101075816B1 (ko) * | 2004-09-22 | 2011-10-25 | 아지노모토 가부시키가이샤 | 종합 경장 영양 조성물 |
MY146103A (en) * | 2006-10-19 | 2012-06-29 | Nestec Sa | Methods of providing long-term nutrition |
DK2081597T3 (da) * | 2006-10-19 | 2012-07-23 | Nestec Sa | Lang-tids enteral føde til opretholdelse |
AU2007312216B2 (en) * | 2006-10-19 | 2011-03-31 | Nestec S.A. | Long-term feed - cancer patient |
-
2007
- 2007-10-17 MY MYPI20091014A patent/MY148276A/en unknown
- 2007-10-17 CA CA2664139A patent/CA2664139C/en not_active Expired - Fee Related
- 2007-10-17 WO PCT/EP2007/061098 patent/WO2008046865A2/en active Application Filing
- 2007-10-17 AU AU2007312284A patent/AU2007312284B2/en not_active Ceased
- 2007-10-17 CN CNA2007800376342A patent/CN101522056A/zh active Pending
- 2007-10-17 JP JP2009532799A patent/JP2010513226A/ja active Pending
- 2007-10-17 MX MX2009003239A patent/MX2009003239A/es active IP Right Grant
- 2007-10-17 CN CN201310460015.1A patent/CN103494196A/zh active Pending
- 2007-10-17 BR BRPI0717410-1A2A patent/BRPI0717410A2/pt not_active IP Right Cessation
- 2007-10-17 RU RU2009118587/13A patent/RU2406411C1/ru not_active IP Right Cessation
- 2007-10-17 US US12/444,936 patent/US20100094246A1/en not_active Abandoned
- 2007-10-17 EP EP07821463A patent/EP2081449A2/en not_active Withdrawn
- 2007-10-19 CL CL2007003018A patent/CL2007003018A1/es unknown
-
2009
- 2009-03-08 IL IL197475A patent/IL197475A0/en unknown
- 2009-03-20 CO CO09029376A patent/CO6160277A2/es unknown
- 2009-05-18 ZA ZA200903406A patent/ZA200903406B/xx unknown
-
2013
- 2013-04-10 JP JP2013082097A patent/JP6096571B2/ja not_active Expired - Fee Related
- 2013-06-10 US US13/914,200 patent/US20130296234A1/en not_active Abandoned
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06253774A (ja) * | 1993-03-08 | 1994-09-13 | Shinichi Sakai | 健康食品として優れたマヨネ−ズソ−スの製造法 |
JPH08231411A (ja) * | 1995-01-13 | 1996-09-10 | Clintec Nutrition Co | 年配患者への栄養供給方法 |
JP2001316274A (ja) * | 2000-05-08 | 2001-11-13 | Asahi Kasei Corp | 経管栄養剤およびその製造方法 |
JP2004527501A (ja) * | 2001-03-05 | 2004-09-09 | ピー. アーネスト,スティーヴン | 経腸処方 |
WO2003022288A1 (fr) * | 2001-09-07 | 2003-03-20 | Meiji Dairies Corporation | Compositions nutritionnelles permettant de reguler le niveau de glucose sanguin |
JP2005261384A (ja) * | 2004-03-22 | 2005-09-29 | Yasuko Morita | クルミ和え衣及びクルミ豆腐 |
JP2006149371A (ja) * | 2004-08-24 | 2006-06-15 | Asama Chemical Co Ltd | 乳清タンパク食品 |
JP2006094740A (ja) * | 2004-09-29 | 2006-04-13 | Asama Chemical Co Ltd | 乳清タンパク食品 |
JP2006104147A (ja) * | 2004-10-07 | 2006-04-20 | Otsuka Pharmaceut Factory Inc | 経口・経腸栄養組成物 |
JP2006131611A (ja) * | 2004-10-07 | 2006-05-25 | Otsuka Pharmaceut Factory Inc | 骨代謝・たんぱく質代謝改善用栄養組成物 |
JP2006230346A (ja) * | 2005-02-28 | 2006-09-07 | Asama Chemical Co Ltd | 分散性の改善された乳由来のタンパク組成物 |
Also Published As
Publication number | Publication date |
---|---|
AU2007312284A1 (en) | 2008-04-24 |
MY148276A (en) | 2013-03-29 |
CN101522056A (zh) | 2009-09-02 |
CA2664139A1 (en) | 2008-04-24 |
IL197475A0 (en) | 2009-12-24 |
RU2406411C1 (ru) | 2010-12-20 |
AU2007312284B2 (en) | 2011-03-03 |
BRPI0717410A2 (pt) | 2013-11-12 |
WO2008046865A2 (en) | 2008-04-24 |
CO6160277A2 (es) | 2010-05-20 |
EP2081449A2 (en) | 2009-07-29 |
CA2664139C (en) | 2013-08-13 |
ZA200903406B (en) | 2010-07-28 |
WO2008046865A3 (en) | 2008-12-11 |
CN103494196A (zh) | 2014-01-08 |
US20100094246A1 (en) | 2010-04-15 |
JP6096571B2 (ja) | 2017-03-15 |
US20130296234A1 (en) | 2013-11-07 |
CL2007003018A1 (es) | 2009-01-23 |
MX2009003239A (es) | 2009-04-08 |
JP2010513226A (ja) | 2010-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6096571B2 (ja) | 高齢者に対する長期栄養供給 | |
CN101325882B (zh) | 包含长链多不饱和脂肪酸的营养补充剂 | |
JP5787480B2 (ja) | 維持のための長期経腸栄養供給 | |
JP5860704B2 (ja) | 水中オメガ−3強化された魚油型非経口栄養エマルション | |
JP5600232B2 (ja) | 遊離アミノ酸含有組成物 | |
Baker et al. | Guidelines for nutritional care for infants with cholestatic liver disease before liver transplantation | |
JPH08231411A (ja) | 年配患者への栄養供給方法 | |
JP2012197293A (ja) | 総合経腸栄養組成物 | |
JPH1118725A (ja) | 糖尿病患者用栄養組成物 | |
WO2002098242A1 (en) | Calorically dense liquid oral supplement | |
WO2008046870A1 (en) | Long-term feed - cancer patient | |
EP3085249A1 (en) | A high protein nutritional composition | |
WO2023282316A1 (ja) | 経腸栄養製剤 | |
RU2361409C1 (ru) | Состав безбелковой смеси для диетического питания детей с наследственными нарушениями аминокислотного обмена | |
MX2008007189A (es) | Suplemento nutricional que contieneacidos grasos poliinsaturados de cadena-larga | |
AU2002312973A1 (en) | Calorically dense liquid oral supplement |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140527 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20140804 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140807 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20141106 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150106 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20150318 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20151104 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20170216 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6096571 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |